MARYAM ASMA: Open Payments
NPI 1760217905 · MARYLAND HEIGHTS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$162 in 8 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $13 · 2025 $162
Food & beverage: $162
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: CAPLYTA, AUSTEDO XR, INGREZZA, UZEDY, FANAPT.
Industry payments across MO — which companies pay providers there.
